Konkurencja i konsument · 19/06/1996

Upjohn Company and Others Agree to Divest Assets to Settle Prohibited Trade Practices Allegations

The Upjohn Company, along with other entities, has agreed to divest Pharmacia Aktiebolag's 9-AC assets, a colorectal cancer treatment drug, within 12 months to settle allegations of violating federal law on unfair or deceptive acts and unfair competition methods, with the FDA overseeing the transaction.